Cargando…
EPA guidance on assessment of negative symptoms in schizophrenia
BACKGROUND: During the last decades, a renewed interest for negative symptoms (NS) was brought about by the increased awareness that they interfere severely with real-life functioning, particularly when they are primary and persistent. METHODS: In this guidance paper, we provide a systematic review...
Autores principales: | Galderisi, S., Mucci, A., Dollfus, S., Nordentoft, M., Falkai, P., Kaiser, S., Giordano, G. M., Vandevelde, A., Nielsen, M. Ø., Glenthøj, L. B., Sabé, M., Pezzella, P., Bitter, I., Gaebel, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080207/ https://www.ncbi.nlm.nih.gov/pubmed/33597064 http://dx.doi.org/10.1192/j.eurpsy.2021.11 |
Ejemplares similares
-
EPA guidance on treatment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022) -
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022) -
EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination
por: Gaebel, W., et al.
Publicado: (2020) -
An EPA for better Bedside Teaching
por: van Dam, Marjel, et al.
Publicado: (2021)